{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T03:46:19Z","timestamp":1780371979317,"version":"3.54.1"},"update-to":[{"DOI":"10.1002\/14651858.cd004447.pub2","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2021,10,7]],"date-time":"2021-10-07T00:00:00Z","timestamp":1633564800000}}],"reference-count":38,"publisher":"Wiley","issue":"10","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd004447.pub3","type":"journal-article","created":{"date-parts":[[2021,10,9]],"date-time":"2021-10-09T07:31:59Z","timestamp":1633764719000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Recombinant growth hormone therapy for X-linked hypophosphatemia in children"],"prefix":"10.1002","volume":"2021","author":[{"given":"Sherie","family":"Smith","sequence":"additional","affiliation":[{"name":"Division of Child Health, Obstetrics & Gynaecology (COG), School of Medicine; University of Nottingham; Nottingham UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tracey","family":"Remmington","sequence":"additional","affiliation":[{"name":"Department of Women's and Children's Health; University of Liverpool; Liverpool UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2021,10,7]]},"reference":[{"issue":"6","key":"10.1002\/14651858.CD004447.pub3-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1007\/BF00868733","article-title":"Stimulation of growth hormone secretion in children with x-linked hypophosphatemia","volume":"9","author":"Seikaly","year":"1995","journal-title":"Pediatric Nephrology"},{"issue":"5","key":"10.1002\/14651858.CD004447.pub3-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1542\/peds.100.5.879","article-title":"The effect of recombinant human growth hormone in children with X-linked hypophosphatemia","volume":"100","author":"Seikaly","year":"1997","journal-title":"Pediatrics"},{"issue":"12","key":"10.1002\/14651858.CD004447.pub3-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"E2097","DOI":"10.1210\/jc.2011-0399","article-title":"Three-year growth hormone treatment in short children with X-linked hypophosphatemic rickets: effects on linear growth and body disproportion","volume":"96","author":"\u017divi\u010dnjak","year":"2011","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"issue":"9","key":"10.1002\/14651858.CD004447.pub3-BIB0004|cit4","first-page":"1484","article-title":"Treatment with recombinant human growth hormone in severely growth retarded children with x-linked hypophosphatemic rickets results in catch-up growth and harmonization of body disproportion","volume":"22","author":"\u017divi\u010dnjak","year":"2007","journal-title":"Pediatric Nephrology"},{"issue":"3","key":"10.1002\/14651858.CD004447.pub3-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s00467-017-3820-3","article-title":"Effects of growth hormone treatment on adult height in severely short children with X-linked hypophosphatemic rickets","volume":"33","author":"Meyerhoff","year":"2018","journal-title":"Pediatric Nephrology"},{"key":"10.1002\/14651858.CD004447.pub3-BIB0006|cit6","unstructured":"Effects of GH on Body Proportions and Final Height in X-Linked Hypophosphatemic Rickets clinicaltrials.gov\/ct2\/show\/NCT00473187"},{"issue":"2","key":"10.1002\/14651858.CD004447.pub3-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1067\/mpd.2001.108955","article-title":"Effect of growth hormone treatment on final height, phosphate metabolism, and bone mineral density in children with X-linked hypophosphatemic rickets","volume":"138","author":"Baroncelli","year":"2001","journal-title":"Journal of Pediatrics"},{"issue":"Suppl 4","key":"10.1002\/14651858.CD004447.pub3-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/S0929-693X(99)80191-2","article-title":"Growth hormone treatment of familial hypophosphatemic rickets","volume":"5","author":"Saggese","year":"1998","journal-title":"Archives de Pediatrie"},{"issue":"3","key":"10.1002\/14651858.CD004447.pub3-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S0022-3476(95)70070-6","article-title":"Long-term growth hormone treatment in children with renal hypophosphatemic rickets: effects on growth, mineral metabolism, and bone density","volume":"127","author":"Saggese","year":"1995","journal-title":"Journal of Pediatrics"},{"key":"10.1002\/14651858.CD004447.pub3-BIB0010|cit10","first-page":"12","article-title":"Beneficial effects of growth hormone therapy for ossification defects after bone distraction in X linked hypophosphataemic rickets","volume":"12","author":"Canete","year":"2014","journal-title":"BMJ Case Reports"},{"issue":"8","key":"10.1002\/14651858.CD004447.pub3-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1007\/s00134-003-1872-2","article-title":"Intravenous phosphate in the intensive care unit: more aggressive repletion regimens for moderate and severe hypophosphatemia","volume":"29","author":"Charron","year":"2003","journal-title":"Intensive Care Medicine"},{"issue":"18","key":"10.1002\/14651858.CD004447.pub3-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1056\/NEJM198010303031802","article-title":"Bone response to phosphate salts, ergocalciferol, and calcitriol in hypophosphatemic vitamin D-resistant rickets","volume":"303","author":"Glorieux","year":"1980","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD004447.pub3-BIB0013|cit13","unstructured":"Growth hormone treatment in children with hypophosphatemic rickets www.clinicaltrials.gov\/ct2\/show\/NCT02720770"},{"issue":"5","key":"10.1002\/14651858.CD004447.pub3-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/s004670050340","article-title":"X-linked hypophosphatemia: effects of treatment with recombinant human growth hormone","volume":"11","author":"Reusz","year":"1997","journal-title":"Pediatric Nephrology"},{"key":"10.1002\/14651858.CD004447.pub3-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ghir.2017.08.001","article-title":"Two-year recombinant human growth hormone (rhGH) treatment is more effective in pre-pubertal compared to pubertal short children with X-linked hypophosphatemic rickets (XLHR)","volume":"36","author":"Rothenbuhler","year":"2017","journal-title":"Growth Hormone & Igf Research"},{"issue":"2","key":"10.1002\/14651858.CD004447.pub3-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1203\/PDR.0b013e318175d788","article-title":"Urinary prostaglandins and the effect of indomethacin on phosphate excretion in children with hypophosphatemic rickets","volume":"64","author":"Seikaly","year":"2008","journal-title":"Pediatric Research"},{"issue":"10","key":"10.1002\/14651858.CD004447.pub3-BIB0017|cit17","first-page":"1165","article-title":"Growth hormone therapy in hypophosphatemic rickets","volume":"145","author":"Wilson","year":"1991","journal-title":"American Journal of Diseases of Children"},{"issue":"6","key":"10.1002\/14651858.CD004447.pub3-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1002\/jbmr.5650050610","article-title":"A short course of recombinant human growth hormone treatment stimulates osteoblasts and activates bone remodeling in normal human volunteers","volume":"5","author":"Brixen","year":"1990","journal-title":"Journal of Bone and Mineral Research"},{"issue":"4","key":"10.1002\/14651858.CD004447.pub3-BIB0019|cit19","first-page":"331","article-title":"Effects of short-term growth hormone treatment on PTH, calcitriol, thyroid hormones, insulin and glucagon","volume":"127","author":"Brixen","year":"1992","journal-title":"Acta Endocrinology"},{"key":"10.1002\/14651858.CD004447.pub3-BIB0020|cit20","doi-asserted-by":"crossref","unstructured":"Bryant J Cave C Mihaylova B Chase D McIntyre L Gerard K Clinical effectiveness and cost-effectiveness of growth hormone in children: a systematic review and economic evaluation Health Technology Assessment 2002 6 18 1 168","DOI":"10.3310\/hta6180"},{"key":"10.1002\/14651858.CD004447.pub3-BIB0021|cit21","unstructured":"Veritas Health Innovation Covidence"},{"key":"10.1002\/14651858.CD004447.pub3-BIB0022|cit22","unstructured":"Deeks JJ Higgins JP Altman DG Chapter 10: Analysing data and undertaking meta-analyses. \u00a0In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.2\u00a0(updated February\u00a02021). Cochrane, 2021 Available from www.training.cochrane.org\/handbook"},{"issue":"10","key":"10.1002\/14651858.CD004447.pub3-BIB0023|cit23","first-page":"3615","article-title":"Mutational analysis of PHEX gene in X-linked hypophosphatemia","volume":"83","author":"Dixon","year":"1998","journal-title":"Journal of Clinical Endocrinology & Metabolism"},{"issue":"1","key":"10.1002\/14651858.CD004447.pub3-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1093\/ije\/31.1.140","article-title":"Meta-analyses involving cross-over trials: methodological issues","volume":"31","author":"Elbourne","year":"2002","journal-title":"International Journal of Epidemiology"},{"issue":"4","key":"10.1002\/14651858.CD004447.pub3-BIB0025|cit25","first-page":"839","article-title":"Effects of calcitriol and phosphorus therapy on the growth of patients with X-linked hypophosphatemia","volume":"76","author":"Friedman","year":"1993","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"issue":"5","key":"10.1002\/14651858.CD004447.pub3-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/S0022-3476(87)80245-7","article-title":"Nephrocalcinosis and its relationship to treatment of hereditary rickets","volume":"111","author":"Goodyer","year":"1987","journal-title":"Journal of Pediatrics"},{"issue":"8","key":"10.1002\/14651858.CD004447.pub3-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1007\/BF02079060","article-title":"Disproportionate growth following long-term growth hormone treatment in short children with X-linked hypophosphataemia","volume":"154","author":"Haffner","year":"1995","journal-title":"European Journal of Pediatrics"},{"issue":"7","key":"10.1002\/14651858.CD004447.pub3-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/s41581-019-0152-5","article-title":"Clinical practice recommendations for the diagnosis and management of X-linked hypophosphataemia","volume":"15","author":"Eastwood Deborah","year":"2019","journal-title":"Nature Reviews Nephrology"},{"issue":"3","key":"10.1002\/14651858.CD004447.pub3-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1210\/endo-123-3-1225","article-title":"Dietary phosphorus and 1,25-dihydroxyvitamin D metabolism: influence of insulin-like growth factor I","volume":"123","author":"Halloran","year":"1988","journal-title":"Endocrinology"},{"issue":"4","key":"10.1002\/14651858.CD004447.pub3-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/BF00862524","article-title":"Regulation of renal phosphate reabsorption during development: implications from a new model of growth hormone deficiency","volume":"4","author":"Haramati","year":"1990","journal-title":"Pediatric Nephrology"},{"issue":"7414","key":"10.1002\/14651858.CD004447.pub3-BIB0031|cit31","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"\u00a0Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD004447.pub3-BIB0032|cit32","unstructured":"Higgins JP Altman DG Chapter 8: Assessing risk of bias in included studies. In: Higgins JP, Churchill R, Chandler J, Cumpston MS, editor(s), Cochrane Handbook for Systematic Reviews of Interventions version 5.2.0 (updated June 2017). The Cochrane Collaboration, 2017 Available from www.training.cochrane.org\/handbook"},{"issue":"3","key":"10.1002\/14651858.CD004447.pub3-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1159\/000167592","article-title":"Increase in renal plasma flow and glomerular filtration rate during growth hormone treatment may be mediated by insulin-like growth factor I","volume":"8","author":"Hirschberg","year":"1988","journal-title":"American Journal of Nephrology"},{"issue":"6","key":"10.1002\/14651858.CD004447.pub3-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1210\/jcem.87.6.8688","article-title":"Molecular pathogenesis of hypophosphatemic rickets","volume":"87","author":"Jan de Beur","year":"2002","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1002\/14651858.CD004447.pub3-BIB0035|cit35","unstructured":"Lefebvre C Glanville J Briscoe S Littlewood A Marshall C Chapter 4: Searching for and selecting studies. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editor(s). Cochrane Handbook for Systematic Reviews of Interventions version 6.2\u00a0(updated February\u00a02021). Cochrane, 2021 Available from www.training.cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD004447.pub3-BIB0036|cit36","first-page":"3717","volume-title":"The Metabolic and Molecular Basis of Inherited Disease","volume":"1","author":"Rasmussen","year":"1995"},{"key":"10.1002\/14651858.CD004447.pub3-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ghir.2017.08.001","article-title":"Two-year recombinant human growth hormone (rhGH) treatment is more effective in pre-pubertal compared to pubertal short children with X-linked hypophosphatemic rickets (XLHR)","volume":"36","year":"2017","journal-title":"Growth Hormone and IGF Research"},{"issue":"1","key":"10.1002\/14651858.CD004447.pub3-BIB0038|cit38","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004447.pub2","article-title":"Recombinant growth hormone therapy for X-linked hypophosphatemia in children","author":"Yang","year":"2005","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","deposited":{"date-parts":[[2023,1,10]],"date-time":"2023-01-10T14:22:54Z","timestamp":1673360574000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD004447.pub3"}},"subtitle":[],"editor":[{"name":"Cochrane Cystic Fibrosis and Genetic Disorders Group","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2021,10,7]]},"references-count":38,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2021,10]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd004447.pub3","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,7]]}}}